Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5104796 | Value in Health | 2017 | 9 Pages |
Abstract
We found evidence that benefit descriptions influence elicited preferences for the benefit-risk characteristics of injectable diabetes treatment. These findings argue for using carefully defined effectiveness measures to accurately take account of the patient perspective in benefit-risk assessments.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Lill-Brith MSc, F. Reed PhD, Morten Raun PhD, Trine Kjær,